ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

In Brief: HHS Names Deputy HCFA Administrator; M.D. Anderson’s Error-Free Record Honored

July 4, 1997

High-Priority Radiation Therapy Research Projects Approved By DCT Board of Counselors

March 26, 1976

IOM Report: Seek More Comment From Public On Priorities, NIH Told

July 17, 1998

In Their Own Words: A 64-page Internal Report with over 1,500 Faculty Comments on MD Anderson Morale

March 29, 2013

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014